SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-022350
Filing Date
2021-09-10
Accepted
2021-09-09 21:46:22
Documents
72
Period of Report
2021-07-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1020762
2 ex31-1.htm EX-31.1 11223
3 ex31-2.htm EX-31.2 20093
4 ex32-1.htm EX-32.1 4529
5 ex32-2.htm EX-32.2 4675
  Complete submission text file 0001493152-21-022350.txt   5866782

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adxs-20210731.xsd EX-101.SCH 42984
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adxs-20210731_cal.xml EX-101.CAL 59445
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adxs-20210731_def.xml EX-101.DEF 208081
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adxs-20210731_lab.xml EX-101.LAB 369072
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adxs-20210731_pre.xml EX-101.PRE 308677
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1095039
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 211245709
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences